Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
Main Authors: | Ahmad Nanaa, David Viswanatha, Zhuoer Xie, Dragan Jevremovic, Phuong Nguyen, Mohamad E. Salama, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Mrinal Patnaik, Animesh Pardanani, Hassan B. Alkhateeb, Mithun Shah, William Hogan, Ayalew Tefferi, Mark Litzow, Rong He, Aref Al-Kali |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-021-00517-0 |
Similar Items
-
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study
by: Zhuoer Xie, et al.
Published: (2021-03-01) -
Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points
by: Naseema Gangat, et al.
Published: (2020-11-01) -
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
by: Maansi Joshi, et al.
Published: (2021-03-01) -
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
by: Kebede H. Begna, et al.
Published: (2021-03-01) -
Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets
by: Pashtoon M. Kasi, et al.
Published: (2016-01-01)